#eskd
LightNews LightNews
rheaultm.bsky.social
Dr Hugh McCarthy: What if we did genetic testing on all children with ESKD? Chinese study shows hit rate of 46.7% #IPNA2025 pubmed.ncbi.nlm.nih.gov/39363361/
February 19, 2025 at 7:41 AM
jenna-m-norton.bsky.social
CMS isn’t even collecting race and ethnicity data on the 2728 form for end stage kidney disease. That’s been a primary source of research data in ESKD.

jamanetwork.com/journals/jam...
Nonreporting of Race and Ethnicity in Medical Research Harms Us All
At JAMA Internal Medicine, we have become increasingly aware that some US researchers are unable to report on race or ethnicity as demographic variables to describe their sample or to conduct stratifi...
jamanetwork.com
September 1, 2026 at 11:30 PM
kimk-research.bsky.social
For anyone who does not understand what post exertional malaise (#PEM) feels like... this was my day today. Not every day is like this, but you get the drift.

#longCovid #ESKD #immunocompromised #pericarditis
For anyone who does not understand what post exertional malaise (#PEM) feels like... this was my day today. Not every day is like this, but you get the drift. #longCovid #ESKD #immunocompromised #pericarditis
February 14, 2025 at 7:06 AM
asnpublications.bsky.social
Dapagliflozin improves estimated CVD and ESKD risk in T1D participants, emphasizing the need for cardiorenal outcome trials in people living with T1D. bit.ly/CJASN0641
#ASNCJASN
March 5, 2025 at 6:15 PM
grahamabra.bsky.social
Have hyperglycemia (and other DM badness) been hiding in plain sight in ESKD?

Probably.

Great study using CGMs in ESKD.

Pts with treated DM, mean TIR only 43% while mean HbA1c was 7.0%

journals.lww.com/jasn/abstrac...
Glycemia Assessed by Continuous Glucose Monitoring among... : Journal of the American Society of Nephrology
ilure and its treatments disrupt glucose homeostasis in ways that may promote both hyperglycemia and hypoglycemia. Continuous glucose monitoring (CGM) delineates detailed glycemic profiles, but publis...
journals.lww.com
September 13, 2025 at 7:16 PM
garysinger.bsky.social
One topic we haven’t discussed is the use (or non-use) of RAASi in patients with ESKD. Thoughts?

#NephJC
December 18, 2024 at 2:55 AM
voidedmike.bsky.social
Old photo of me in Deltona, FL, 2017—back when I was a manager, before my disabilities. I keep it to remind myself I was important once. Now, dealing with ESKD & blindness, life is different, but I’m still here. #Throwback #DisabilityAwareness #Blindness #ESKD #LifeChanges #FlashbackFriday
March 1, 2025 at 3:32 AM
kimk-research.bsky.social
I am #immunocompromised and have been housebound since early 2020 with #longCovid #ESKD and #IgGdeficiency. The following article really hits home with me and many others in the #chronicillness/#disabled community. 😔
February 1, 2025 at 4:55 PM
nephroseeker.medsky.social
Thoughtful and controversial blog from Last Month in Nephrology #NephSky #MedSy

Albuminuria as an ESKD surrogate may be a statistical mirage, limited by imprecision and overinterpretation

However, it moved nephrology forward and made studies happen
lastmonthinnephrology.wordpress.com
Last Month in Nephrology
lastmonthinnephrology.wordpress.com
September 6, 2025 at 4:29 PM
hswapnil.medsky.social
Pulmonary embolism in ESKD: very interesting descriptive study in @jama.com open

jamanetwork.com/journals/jam...
~ 1% incidence per year (likely underdiagnosed IMO)
- Anticoagulants not used universally (and maybe don’t work)
- Slightly more common in HD than PD

#NephSky
Table. Baseline Characteristics of Patients With ESKD and Those With PE
March 18, 2025 at 11:07 AM
hswapnil.medsky.social
Coming up this week - @ericweinhandl.bsky.social will be presenting on ESKD epidemiology at the Ottawa Nephrology #NephGR

#NephSky
(DM me to be added to the email list to join zoom)
invitation slide for Neph grand rounds with Dr Eric Weinhandl
November 20, 2024 at 1:14 PM
katiekwonmd.bsky.social
GSK has withdrawn their NDA (new drug application) for Jesduvroq (daprodustat) in the US and it will be off the market as of 12/15/24. Uptake of the HFI-PHI was very slow. Vafseo will be the only drug in the class available. #anemia #ESKD
November 21, 2024 at 10:22 AM
kidneyboy.bsky.social
Obesity was an important risk factor for progression to ESKD in ADPKD for patients with eGFR > 60, but not for patients with eGFR 25-59.

journals.lww.com/cjasn/fullte...
May 7, 2025 at 1:41 PM
kidneyint.bsky.social
The effects of #plasmaexchange and #glucocorticoids on early kidney function among patients with #ANCA-associated #vasculitis in the PEXIVAS trial

doi.org/10.1016/j.kint.2024.11.029

#OpenAccess #glomerulonephritis #ESKD #NephSky #MedSky
January 15, 2025 at 5:53 PM
med-office-j.bsky.social
【米国退役軍人CKD例でSGLT2阻害薬とGLP-1RAの腎保護作用を比較すると？/CJASN】Sep.29

米国退役軍人、ステージ3、4 CKDでSGLT2阻害薬開始の78,354例とGLP-RA開始28,365例、PS重み付比較——

・11カ月間の「ESKD・腎機能4割以上の持続的低下・死亡」に両
　群間で有意差なし。
・一方、腎機能低下とESKDリスクはGLP-1RAで有意に高。

抄録🔗 x.gd/9kzOD
Comparative Renal Effectiveness of GLP-1RA and... : Clinical Journal of the American Society of Nephrology
Objective:To address limited comparative evidence in older, clinically complex patients with type 2 diabetes and moderate-to-advanced chronic kidney...
x.gd
September 29, 2026 at 9:55 PM
jwaitz.bsky.social
Were there phos/PTH quality metrics for ESKD that needed to be paused for the trial? #nephjc
August 6, 2025 at 1:25 AM
edgarvlermamd.medsky.network
Have you started/ continued SGLT2 inhibitors (SGLT2i) in patients with ESKD ⁉️
#Nephpearls #AskRenal #NephSky
edgarvlermamd.medsky.network Edgar V. Lerma 🇵🇭 @edgarvlermamd.medsky.network · Mar 11
Is There a Role for SGLT2 Inhibitors (SGLT2i) in Patients with End-Stage Kidney Disease (ESKD) ⁉️ ca. 2024
#Nephpearls #NephSky

👉🏼 pubmed.ncbi.nlm.nih.gov/38913113/
March 11, 2025 at 9:02 PM
caulimovirus.bsky.social
Half a century of hemodialysis!

pmc.ncbi.nlm.nih.gov/articles/PMC...
Half a century of haemodialysis: two patient journeys
The history of renal replacement therapy (RRT) for end-stage kidney disease (ESKD) started in 1960 and has reached, in these six decades, goals initially unforeseen. This report describes two patients...
pmc.ncbi.nlm.nih.gov
October 2, 2025 at 2:46 AM
ajkd.bsky.social
Longitudinal Income Dynamics and Risk of End-Stage Kidney Disease in Type 2 Diabetes: A South Korean Population–Based Cohort Study

bit.ly/KangOI25

#ESKD
May 5, 2025 at 4:05 PM
kimk-research.bsky.social
Sage advice. If your #immune system is destroyed, you're housebound as I have been since 2020 following a #Covid19 infection and 3 diagnosed #chronicillnesses. One that damaged my kidneys beyond repair. Protect yourself and others from living in isolation!

#wearamask #longCovid #ESKD #IgGdeficiency
scottsquires.bsky.social Scott Squires @scottsquires.bsky.social · Jan 31
We share the air.
If you used to mask, you should restart if you value your health. Covid is still here. Covid isn't any milder. It's not a cold. It's just as dangerous as ever and more infectious. Covid moves likes invisible deadly smoke. The devastation of Covid is even more clear We share the air There's still a 1 in 5 chance of getting long Covid for every infection and each re-infection has worst odds and outcomes. Up to 60% of Covid infections are from an asymptomatic person which is why wearing a mask is important. You could be spreading Covid without realizing it. We share the air so we're all in this together. Please do you part by protecting yourself and others, making places safer for everyone. Mask Up
February 1, 2025 at 2:54 PM
cynrancour.bsky.social
Periorbital edema +3.
CKD...ESKD?
July 2, 2026 at 11:45 PM
kidneystories.bsky.social
History of Preeclampsia Associated With Increased CKD, ESKD Risk - AJMC - goo.gl/alerts/KLw1gZ #GoogleAlerts
History of Preeclampsia Associated With Increased CKD, ESKD Risk | AJMC
Research reveals a potential link between preeclampsia and increased risks of chronic kidney disease, urging careful monitoring post pregnancy.
goo.gl
January 17, 2026 at 11:50 AM
kireports.bsky.social
Risk of End-Stage Kidney Disease #ESKD and #Topiramate Use

#VisualAbstract by @Cteodosiu

www.kireports.org/ar...
July 23, 2025 at 3:00 PM
ajkd.bsky.social
Effect of Dual RAAS Blockade and Intensive BP Lowering on Risk of ESKD and Death in ADPKD: Long-Term Follow-Up of the HALT-PKD Trials

https://bit.ly/4g6t82A (FREE)
January 29, 2025 at 11:00 PM
nephroseeker.medsky.social
The VALUE trial reminded me of old #nephsky trials where ESKD or nothing counted as outcome
👉 no significant difference between amlodipine vs valsartan
⬇️ESKD with BP <135

🤔Interestingly, 20% of valsartan group was on ACEi
🙃accounting for Cr, but not for eGFR (?)

www.ejinme.com/article/S095...
March 30, 2025 at 10:31 PM